Hexima Is A Clinical Stageanti Infectives Focused Biotechnology Company Engaged In The Research And Development Of Plant Defensin Peptides For Applications As Human Therapeuticsour Lead Product Candidatepezadeftideformally Hxp124Applied In A Topical Formulationis A Potential New Prescription Treatment For Toenail Fungal Infectionsor Onychomycosis Hexima Is Currently Conducting An Australian Phase Iib Clinical Trial Testing Pezadeftide For The Treatment Of Onychomycosishexima Holds Grantedlong Life Patents Protecting Pezadeftide In Major Markets Globally
